Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2869814

PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    28.6.2013
  • EP published:
    6.4.2016
  • EP application number:
    13735235.7
  • Max expiry date:
    27.6.2033
  • Title:
    PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE

Timeline

Today
28.6.2013EP application
6.4.2016EP Publication

Owner

  • Name:
    Bayer Pharma Aktiengesellschaft
  • Address:
    Müllerstrasse 178, 13353, Berlin, DE

Inventor

  • Name:
    BENKE, Klaus
  • Address:
    Bergisch Gladbach, DE
  • Name:
    NEUMANN, Heike
  • Address:
    Wuppertal, DE
  • Name:
    MÜCK, Wolfgang
  • Address:
    Wuppertal, DE

Priority

  • Number:
    12174797
  • Date:
    3.7.2012
  • Country:
    EP

Classification

  • Categories:
    A61K 9/20, A61K 31/5377, A61K 9/00, A61K 9/24

Upload documents